References
- Hewlett EL, Edwards KM. Clinical practice. Pertussis - not just for kids. N Engl J Med. 2005;352:1215–1222.
- WHO. Global routine vaccination coverage, 2011. Wkly Epidemiol Rec. 2012;44:432–435.
- WHO. Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec. 2010;85:385–400.
- Cherry JD. Pertussis in the preantibiotic and prevaccine era, with emphasis on adult pertussis. Clin Infect Dis. 1999;28(Suppl 2):S107–S111.
- Storsaeter J, Wolter J, Locht C. Pertussis vaccines. In: Locht C, editor. Bordetella Molecular Microbiology. Norfork, UK: Horizon Press; 2007. p. 245–288.
- Jefferson T, Rudin M, DiPietrantonj C. Systematic review of the effects of pertussis vaccines in children. Vaccine. 2003;21:2003–2014.
- Witt MA, Katz PH, Witt DJ. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis. 2012;54:1730–1735.
- WHO. Meeting of the strategic advisory group of experts on immunization, April 2014 – conclusions and recommendations. Wkly Epidemiol Rec. 2014;89:221–236.
- Althouse BM, Scarpino SV. Asymptomatic transmission and the resurgence of Bordetella pertussis. BMC Med. 2015;13:146.
- Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci USA. 2014;111:787–792.
- Martin SW, Pawloski L, Williams M, et al. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage. Clin Infect Dis. 2015;60:223–227.
- Wearing HJ, Rohani P. Estimating the duration of pertussis immunity using epidemiological signatures. PLoS Pathog. 2009;5:e1000647.
- Versteegh FG, Schellekens JF, Nagelkerke AF, et al. Laboratory-confirmed reinfections with Bordetella pertussis. Acta Paediatr. 2002;91:95–97.
- Mielcarek N, Debrie AS, Raze D, et al. Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. PLoS Pathog. 2006;2:e65.
- Locht C, Mielcarek N. Live attenuated vaccines against pertussis. Expert Rev Vaccines. 2014;13:1147–1158.
- Thorstensson R, Trollfors B, Al-Tawil N, et al. A phase I clinical study of a live attenuated Bordetella pertussis vaccine – BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. PLoS ONE. 2014;9:e83449.
- Amirthalingam G, Andrews N, Campbell H, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet. 2014;384:1521–1528.
- Maertens K, Caboré RN, Huygen K, et al. Pertussis vaccination during pregnancy in Belgium: results of a prospective controlled cohort study. Vaccine. 2016;34:142–150.
- Munoz FM, Bond NH, Maccato M, et al. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. J Am Med Assoc. 2014;311:1760–1769.
- Feunou PF, Mielcarek N, Locht C. Reciprocal interference of maternal and infant immunization in protection against pertussis. Vaccine. 2016;34:1062–1069.